ArticleJapanese journal of clinical oncology2024

Trastuzumab deruxtecan in patients with human epidermal growth factor receptor 2-expressing salivary gland carcinoma: a pooled analysis of two phase I studies.

Shunji Takahashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.